ENDRA Life Sciences (NDRA) Debt Ratio (2020 - 2023)

ENDRA Life Sciences has disclosed Debt Ratio across 4 years of filings, most recently posting 0.0 for Q4 2023.

• In Q4 2023, Debt Ratio rose 37.31% year-over-year to 0.0; the TTM figure through Dec 2023 stood at 0.0 (up 37.31% YoY), while the FY2023 annual figure was 0.0, up 37.31% from the prior year.
• Debt Ratio advanced to 0.0 in Q4 2023, from 0.0 in the prior quarter.
• Over the last five years, Debt Ratio for NDRA reached as high as 0.12 in Q2 2020 and fell as low as 0.0 in Q1 2021.
• The 4-year median for Debt Ratio is 0.0 (2022), against an average of 0.02.
• Annual changes were most pronounced in 2021 — Debt Ratio slumped 98.6% — and 2022, when it surged 72.8%.
• A 4-year view of Debt Ratio shows it stood at 0.04 in 2020, then slumped by 94.25% to 0.0 in 2021, then soared by 38.82% to 0.0 in 2022, then soared by 37.31% to 0.0 in 2023.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.